GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...
Milestone strengthens the company’s leadership in advanced IOL innovation FINEVISION HP, with millions of implantations worldwide, will now be available to U.S. patients Proprietary design features ...
Jeffrey Horn, MD, of Nashville, Tenn.-based Vision for Life, will implant a PanOptix Trifocal Intraocular Lens in a patient Sept. 4. 1. Dr. Horn will complete what is believed to be the first ...
The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...
Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...
Medical technology manufacturer Carl Zeiss Meditec, based in Jena, Germany, has developed a novel trifocal intraocular lens called the ATLISA tri 839MP, which it says represents “the next generation” ...
WALTHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- BVI, a global leader in ophthalmic device innovation, today announced that the U.S. Food and Drug Administration (FDA) has approved its FINEVISION HP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback